DK515686A - Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf - Google Patents

Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf

Info

Publication number
DK515686A
DK515686A DK515686A DK515686A DK515686A DK 515686 A DK515686 A DK 515686A DK 515686 A DK515686 A DK 515686A DK 515686 A DK515686 A DK 515686A DK 515686 A DK515686 A DK 515686A
Authority
DK
Denmark
Prior art keywords
dopamine
beta
procedures
preparation
hydroxylase inhibitors
Prior art date
Application number
DK515686A
Other languages
Danish (da)
English (en)
Other versions
DK515686D0 (da
Inventor
Joseph Alan Finkelstein
Carl Kaiser
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK515686D0 publication Critical patent/DK515686D0/da
Publication of DK515686A publication Critical patent/DK515686A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK515686A 1985-10-31 1986-10-28 Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf DK515686A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/793,513 US4628059A (en) 1985-10-31 1985-10-31 Dopamine-β-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
DK515686D0 DK515686D0 (da) 1986-10-28
DK515686A true DK515686A (da) 1987-05-01

Family

ID=25160085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK515686A DK515686A (da) 1985-10-31 1986-10-28 Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf

Country Status (7)

Country Link
US (1) US4628059A (pt)
EP (1) EP0225718A3 (pt)
JP (1) JPS62108869A (pt)
AU (1) AU597600B2 (pt)
DK (1) DK515686A (pt)
PT (1) PT83626B (pt)
ZA (1) ZA868234B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82542A0 (en) * 1986-05-23 1987-11-30 Smithkline Beckman Corp Triazole derivatives,their preparation and pharmaceutical compositions containing them
US4761415A (en) * 1986-08-28 1988-08-02 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors
AU2948189A (en) * 1987-12-31 1989-08-01 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
CA3082337A1 (en) 2017-12-04 2019-06-13 Bial - Portela & Ca, S.A. Dopamine-b-hydroxylase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271308A (en) * 1968-09-04 1981-06-02 Rohm And Haas Company 4-alkyl-1,2,4-4H-triazole derivatives
US4120864A (en) * 1970-08-26 1978-10-17 Rohm And Haas Company 1,2,4-4H-triazole derivatives
US4082762A (en) * 1975-08-25 1978-04-04 Eli Lilly And Company 4-(2-halophenyl)-1,2,4-triazole-3-thiol compounds
IL82542A0 (en) * 1986-05-23 1987-11-30 Smithkline Beckman Corp Triazole derivatives,their preparation and pharmaceutical compositions containing them
US4761415A (en) * 1986-08-28 1988-08-02 Smithkline Beckman Corporation Dopamine-β-hydroxylase inhibitors

Also Published As

Publication number Publication date
US4628059A (en) 1986-12-09
ZA868234B (en) 1987-12-30
AU6463886A (en) 1987-05-07
PT83626B (en) 1988-11-21
EP0225718A2 (en) 1987-06-16
AU597600B2 (en) 1990-06-07
DK515686D0 (da) 1986-10-28
EP0225718A3 (en) 1988-03-30
PT83626A (en) 1986-11-01
JPS62108869A (ja) 1987-05-20

Similar Documents

Publication Publication Date Title
DK491186A (da) Pyridonderivater og fremgangsmaade til fremstilling deraf
DK554685A (da) Renininhiberende dipeptider og fremgangsmaade til fremstilling deraf
DK162137C (da) Engangsble og fremgangsmaade til fremstilling deraf
DK313086D0 (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK376986D0 (da) Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf
DK301886D0 (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
DK335986A (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
NO166313C (no) Fremgangsmaate og innretning for kontinuerlig fremstillingav surimimasse.
DK103986D0 (da) Quinoloncarboxylsyre-derivat og fremgangsmaade til fremstilling heraf
DK188486D0 (da) Glycopeptid-derivater og fremgangsmaade til fremstilling deraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK303887D0 (da) Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf
DK381886A (da) Medicinsk praeparat og fremgangsmaade til dets fremstilling
DK515786A (da) Inhibitorer for dopamin-beta-hydroxylase samt fremgangsmaade til fremstilling heraf
DK161086A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling og anvendelse deraf
DK4187D0 (da) Triazolylquinolin-derivater og fremgangsmaade til fremstilling deraf
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
NO860092L (no) Korrosjons-inhibitor og fremgangsmaate til fremstilling derav.
DK515686D0 (da) Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
DK317786A (da) Antibakterielt virksomme 7beta-heteroacylamino-4-chlor-cephalosporiner og fremgangsmaade til fremstilling heraf
DK62086A (da) Dopamin-beta-hydroxylase inhibitorer og fremgangsmaade til fremstilling deraf samt midler indeholdende inhibitorerne
DK50686D0 (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf
DK443787A (da) Hydrazonderivater og fremgangsmaade til fremstilling deraf